Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity.
Sepsis is one of the leading causes of acute kidney injury (AKI). Septic patients who develop acute kidney injury (AKI) are at increased risk of death. To date there is no effective treatment for AKI or septic AKI. Based on their anti-inflammatory properties, we examined the effects of nicotinic ace...
Main Authors: | Prodyot K Chatterjee, Michael M Yeboah, Oonagh Dowling, Xiangying Xue, Saul R Powell, Yousef Al-Abed, Christine N Metz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3346807?pdf=render |
Similar Items
-
Silent agonists for α7 nicotinic acetylcholine receptors
by: Roger L. Papke, et al.
Published: (2023-04-01) -
Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice.
by: Prodyot K Chatterjee, et al.
Published: (2017-01-01) -
TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors
by: Teagan R. Wall, et al.
Published: (2017-09-01) -
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
by: Tehila Mizrachi, et al.
Published: (2021-04-01) -
Agrin reduces heterogenous expression of nicotinic acetylcholine receptors in skeletal muscles of septic rats
by: LYU Bixiao, et al.
Published: (2019-06-01)